Back to Ticker
Alivus Life Sciences Limited
NSE: ALIVUS₹1,369
-2.12%EOD · 19 AugMarket Cap
₹16,807 Cr
52W Range
₹1418 / ₹819
Volume
55K
47.8% delivery
1Y Return
+43.4%
P/E Ratio
28.3
P/B Ratio
5.1
ROE
18.4%
Debt / Equity
1.70
Technical Indicators
Full analysis · objective math, not adviceReturns
1D
-2.1%
1W
-0.4%
1M
+24.3%
3M
+32.6%
6M
+50.4%
1Y
+43.4%
Weinstein Stage
Stage 2 — Advancing (uptrend) RSI (14)
76 Overbought
Trend Template
7/7strong
RS vs Nifty (3M)
+34.5pp
Moving Averages (price vs MA)
20-DMA
₹1297
above
50-DMA
₹1201
above
150-DMA
₹1068
above
200-DMA
₹1025
above
From 52W High
-3.5%
From 52W Low
+67.2%
Support (20D)
₹1090
Resistance (20D)
₹1418
Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.
News & FilingsGoogle News + BSE
Alivus Life Sciences Limited Just Recorded A 7.5% EPS Beat: Here's What Analysts Are Forecasting Next
simplywall.st· 3 AugALIVUS Stock Price and Chart — NSE:ALIVUS
TradingView· 10 MayWhy Is Alivus Life Sciences Share Price Falling: Key Reasons and Investor Analysis 2026
Univest· 14 MayAlivus Life Sciences fixes Sep 1 record date for ₹5 dividend
scanx.trade· 6 AugAlivus Life Sciences Ltd. Share Price Live Today
CNBC TV18· 3 JanGlenmark Life Science Share Price
Upstox· 23 Nov
News via Google News · Not verified by IPOpulse · Not investment advice
Community discussion(0)
Sign in to join the discussion.
Sign inNo comments yet — be the first to share your view.